<?xml version="1.0" encoding="UTF-8"?>
<p id="p0280">Moreover, many nodal points used by viruses and chemicals to generate, develop and disperse pathologies and diseases have been used over the last three decades individually or in combination as targets for modern checkpoint therapies through monoclonal antibodies in order to address these diseases (
 <xref rid="bib127" ref-type="bibr">Peng et al., 2016</xref>; 
 <xref rid="bib59" ref-type="bibr">Hafeez et al., 2018</xref>). Transcription factors, membrane receptor signaling pathways, and protein kinase signaling pathways, are all key players of xenobiotic-induced cancer in adults (
 <xref rid="bib40" ref-type="bibr">Eldakroory et al., 2017</xref>) and 
 <italic>children (</italic>
 <xref rid="bib60" ref-type="bibr">Hargrave et al., 2006</xref>), hematological and lymphoid malignancies (
 <xref rid="bib95" ref-type="bibr">Leon et al., 2019</xref>), Alzheimer's disease and Parkinson's disease (
 <xref rid="bib3" ref-type="bibr">Aloizou et al., 2020</xref>) and stroke (
 <xref rid="bib160" ref-type="bibr">Tsatsakis et al., 2019b</xref>). Furthermore, this knowledge has also been valuable for molecular-oriented anti-cancer therapy (
 <xref rid="bib100" ref-type="bibr">Liu et al., 2018</xref>).
</p>
